What it is
Follistatin-344 is a myostatin inhibitor. muscle growth research belongs to the growth-hormone axis class, where human studies examine pulsatile GH release, IGF-1 response, lean-mass dynamics, and recovery quality. Pepture treats Follistatin-344 purely as a tracking target, meaning the app records what you enter without making any clinical recommendation about whether the compound is right for you. That determination belongs with a licensed clinician who knows your full history.
Most research and practitioner use reports subcutaneous (SubQ) injection with a U-100 insulin syringe. Published pharmacokinetic data on this compound is limited; always consult a clinician for timing decisions.
The Pepture library entry for Follistatin-344 exists so that if you are already logging a Follistatin-344 protocol, you can do so with structured fields, cycle calendars, injection-site rotation, and biomarker context rather than a loose notebook. If you are considering starting a protocol with Follistatin-344, speak with a licensed clinician before obtaining or dosing the compound.
Common uses
The uses most commonly logged for Follistatin-344 in the Pepture community align with its performance positioning. Users track Follistatin-344 alongside sleep depth, fasted weight, IGF-1 when available, and strength output, so the protocol's impact can be evaluated over a full cycle rather than by memory.
Clinician-guided dose only.
Pepture makes no claim about efficacy. Follistatin-344 is either FDA-approved, used under a prescription, or labelled for research only depending on the jurisdiction. Confirm the legal and clinical status of Follistatin-344 in your country with a licensed clinician before use.
Reconstitution math
Open the pre-filled Follistatin-344 reconstitution calculator to compute syringe units per dose.
Reconstitution guidance
Reconstitution specifics depend on vial size and supplier. Pepture's in-app calculator handles mg, mL, and syringe unit math once you enter your vial and desired dose.
Stack combinations
Often paired with complementary GH-axis peptides in performance stacks. Pepture flags overlapping half-lives.
Cycle length norms
Tracked users commonly run Varies. Cycle norms vary by individual and by clinician guidance. Pepture lets you configure any on/off window that matches your protocol.
Safety considerations
Every peptide carries context-specific risks. Work with a licensed clinician who knows your medical history before starting or adjusting a protocol. Stop and seek medical attention for severe injection site reactions, unexpected swelling, shortness of breath, persistent elevated heart rate, rash, or any reaction you did not anticipate. Pepture does not assess efficacy or safety for any individual.
Reported Side Effects of Follistatin-344
Effects below are summarised from peer-reviewed literature or regulatory labeling where it exists. Not medical advice. Individual responses vary.
- Water retention and mild peripheral edema Endocrine Reviews
- Joint discomfort and carpal-tunnel-type symptoms at higher doses J Clin Endocrinol Metab
- Transient rise in fasting glucose and HbA1c in sensitive users J Clin Endocrinol Metab
- Increased appetite (orally-active secretagogues) PubMed
- Injection-site redness or itching (injected secretagogues) PubMed
Compare Follistatin-344
How Follistatin-344 stacks up against the peers most users consider.
References
For peer-reviewed literature, search PubMed for Follistatin-344. Pepture does not link to vendor or retail sites.
Disclaimer
The information on this page is for informational purposes only and is not medical, legal, or regulatory advice. Pepture does not sell, supply, prescribe, or recommend any peptide. Many peptides are investigational or restricted in specific jurisdictions.